CA2222965A1 - Oral administration of pneumococcal antigens - Google Patents

Oral administration of pneumococcal antigens Download PDF

Info

Publication number
CA2222965A1
CA2222965A1 CA002222965A CA2222965A CA2222965A1 CA 2222965 A1 CA2222965 A1 CA 2222965A1 CA 002222965 A CA002222965 A CA 002222965A CA 2222965 A CA2222965 A CA 2222965A CA 2222965 A1 CA2222965 A1 CA 2222965A1
Authority
CA
Canada
Prior art keywords
pspa
pneumococcal
pneumococci
host
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002222965A
Other languages
English (en)
French (fr)
Inventor
Masafumi Yamamoto
David E. Briles
Larry S. Mcdaniel
Hiroshi Kiyono
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/458,399 external-priority patent/US6231870B1/en
Priority claimed from US08/482,981 external-priority patent/US6232116B1/en
Priority claimed from US08/657,751 external-priority patent/US6004802A/en
Application filed by Individual filed Critical Individual
Publication of CA2222965A1 publication Critical patent/CA2222965A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA002222965A 1995-06-02 1996-05-31 Oral administration of pneumococcal antigens Abandoned CA2222965A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/458,399 1995-06-02
US08/458,399 US6231870B1 (en) 1995-06-02 1995-06-02 Oral administration of pneumoccal antigens
US08/482,981 US6232116B1 (en) 1991-02-15 1995-06-07 Oral administration of pneumococcal antigens
US08/482,981 1995-06-07
US08/657,751 1996-05-30
US08/657,751 US6004802A (en) 1995-06-02 1996-05-30 Oral administration of pneumococcal antigens

Publications (1)

Publication Number Publication Date
CA2222965A1 true CA2222965A1 (en) 1996-12-12

Family

ID=27412732

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002222965A Abandoned CA2222965A1 (en) 1995-06-02 1996-05-31 Oral administration of pneumococcal antigens

Country Status (6)

Country Link
EP (1) EP0871479A2 (enrdf_load_stackoverflow)
AU (1) AU709368B2 (enrdf_load_stackoverflow)
CA (1) CA2222965A1 (enrdf_load_stackoverflow)
FI (1) FI974376A7 (enrdf_load_stackoverflow)
NO (1) NO975522L (enrdf_load_stackoverflow)
WO (1) WO1996039113A2 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
KR19980067137A (ko) * 1997-01-31 1998-10-15 박원훈 알긴산염 초미세과립구를 이용한 폐렴구균 감연중에 대한 백신
DE19708537A1 (de) * 1997-03-03 1998-09-10 Biotechnolog Forschung Gmbh Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
WO2008109958A1 (en) * 2007-03-15 2008-09-18 Hunter Immunology Limited Methods for evaluation of oral vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2104014C (en) * 1991-02-15 2000-05-02 David E. Briles Structural gene of pneumococcal protein
US6027734A (en) * 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A

Also Published As

Publication number Publication date
AU709368B2 (en) 1999-08-26
FI974376A0 (fi) 1997-12-01
WO1996039113A2 (en) 1996-12-12
NO975522D0 (no) 1997-12-01
FI974376L (fi) 1998-01-26
FI974376A7 (fi) 1998-01-26
EP0871479A4 (enrdf_load_stackoverflow) 1998-11-11
WO1996039113A3 (en) 1997-06-05
NO975522L (no) 1998-02-02
AU6998596A (en) 1996-12-24
EP0871479A2 (en) 1998-10-21

Similar Documents

Publication Publication Date Title
AU2018201768B2 (en) Protein antigens that provide protection against pneumococcal colonization and/or disease
Ivins et al. Recent advances in the development of an improved, human anthrax vaccine
Frasch Vaccines for prevention of meningococcal disease
Alexander et al. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae
US6984385B2 (en) Immunological combination compositions and methods
LEVINE et al. Typhoid vaccines come of age
US20090098157A1 (en) Helicobacter Pylori Vaccination
JP2012501959A (ja) Ｙｅｒｓｉｎｉａｐｅｓｔｉｓ抗原を含む組成物
EP0682950B1 (en) Mucosal administration of pneumococcal antigens
US6232116B1 (en) Oral administration of pneumococcal antigens
US20050260225A1 (en) Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
Robbins et al. Haemophilus influenzae type b
US9310381B2 (en) Engineered type IV pilin of Clostridium difficile
US6004802A (en) Oral administration of pneumococcal antigens
US6231870B1 (en) Oral administration of pneumoccal antigens
AU709368B2 (en) Oral administration of pneumococcal antigens
US5429818A (en) Non-capsulated mutants of Actinobacillus pleuropneumoniae useful as vaccines
Kaplonek et al. A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae
CA2379327A1 (en) Pneumococcal surface protein combination vaccine
Hara et al. Outer membrane proteins as potential candidate vaccine targets
AU734488B2 (en) Mucosal administration of pneumococcal antigens
RU2005779C1 (ru) Штамм бактерий leptospira interrogans "рябухин" серогруппы icterohaemorrhagiae, серовара copenhageni, используемый для приготовления вакцины против лептоспироза
US12048743B2 (en) Glyconjugate vaccines

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued